Glycogen Synthase Kinase-3 (GSK3): Inflammation, Diseases, and Therapeutics
Open accessThe DOI matches its Crossref record; 191 of the 192 references it cites were found in a registry or an index.
Abstract
Deciphering what governs inflammation and its effects on tissues is vital for understanding many pathologies. The recent discovery that glycogen synthase kinase-3 (GSK3) promotes inflammation reveals a new component of its well-documented actions in several prevalent diseases which involve inflammation, including mood disorders, Alzheimer's disease, diabetes, and cancer. Involvement in such disparate conditions stems from the widespread influences of GSK3 on many cellular functions, with this review focusing on its regulation of inflammatory processes. GSK3 promotes the production of inflammatory molecules and cell migration, which together make GSK3 a powerful regulator of inflammation, while GSK3 inhibition provides protection from inflammatory conditions in animal models. The involvement of GSK3 and inflammation in these diseases are highlighted. Thus, GSK3 may contribute not only to primary pathologies in these diseases, but also to the associated inflammation, suggesting that GSK3 inhibitors may have multiple effects influencing these conditions.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“We observed the accumulation of SNAIL-1 into the nucleus of MeT-5A cells incubated with asbestos fibers as a consequence of the phosphorylation and inactivation of GSK-3β, thus allowing SNAIL-1 to translocate into the nucleus and to repress E-cadherin transcription [20,30].”
Citations
Cites
1 retracted
Cuzzocrea, S., Mazzon, E., Paola, R. D., Muià, C., Crisafulli, C., Dugo, L., Collin, M., Britti, D., Caputi, A. P., & Thiemermann, C. (2006) · Clinical Immunology · doi:10.1016/j.clim.2006.03.005 · Cited by 89 · cited 1×
“In other inflammatory conditions, GSK3 inhibitors diminished inflammatory responses in experimentally induced colitis in rats [23] and in arthritis caused by administration of type II collagen in mice [24].”
BackgroundRetractedCalcium's Role in Mechanotransduction during Muscle Development
Benavides Damm, T., & Egli, M. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000356667 · Cited by 14,502
Polazzi, E., Mengoni, I., Caprini, M., Peña-Altamira, E., Kurtys, E., & Monti, B. (2013) · Neurosignals · doi:10.1159/000337115 · Cited by 8,994
Glutamate neurotoxicity and diseases of the nervous system
CHOI, D. (1988) · Neuron · doi:10.1016/0896-6273(88)90162-6 · Cited by 7,972
Inflammation and cancer: back to Virchow?
Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746 · cited 2×
“Inflammation is closely linked to cancer, as the association between immune cells and cancer has been known for over a century [180].”
BackgroundAdipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518
Global and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883 · cited 1×
“type 2 insulin-independent diabetes, which are increasingly prevalent conditions [119–121].”
BackgroundInsulin signalling and the regulation of glucose and lipid metabolism
Saltiel, A. R., & Kahn, C. R. (2001) · Nature · doi:10.1038/414799a · Cited by 5,326 · cited 1×
“type 2 insulin-independent diabetes, which are increasingly prevalent conditions [119–121].”
BackgroundInhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
Cross, D. A. E., Alessi, D. R., Cohen, P., Andjelkovich, M., & Hemmings, B. A. (1995) · Nature · doi:10.1038/378785a0 · Cited by 5,244 · cited 1×
“Insulin receptors in most peripheral tissues, as well as in the brain, stimulate a signaling cascade leading to activation of Akt which phosphorylates, to inhibit, GSK3 [122].”
BackgroundInflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus
Pradhan, A. D. (2001) · JAMA · doi:10.1001/jama.286.3.327 · Cited by 4,433 · cited 1×
“source of a large portion of IL-6 in the blood and elevated IL-6 levels predict the development of type 2 diabetes [147], an interesting link to the finding that GSK3 promotes IL-6 production [8].”
BackgroundInflammation, stress, and diabetes
Wellen, K. E., & Hotamisligil, G. S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25102 · Cited by 4,143 · cited 1×
“signaling [145, 146].”
Mutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837
A molecular mechanism for the effect of lithium on development.
Klein, P. S., & Melton, D. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8455 · Cited by 2,301 · cited 1×
“disorder [47].”
Paradoxical roles of the immune system during cancer development
de Visser, K. E., Eichten, A., & Coussens, L. M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1782 · Cited by 2,256 · cited 1×
“On the other hand, attenuation of innate inflammation following GSK3 inhibition could explain the absence of an effect of lithium alone on tumor formation, since in the absence of infiltration of immune cells, components of tumor development, such as increased cell survival, tissue remodeling, angiogenesis, and suppre…”
BackgroundProtection from obesity-induced insulin resistance in mice lacking TNF-α function
Uysal, K. T., Wiesbrock, S. M., Marino, M. W., & Hotamisligil, G. S. (1997) · Nature · doi:10.1038/39335 · Cited by 2,234
Inflammation: the link between insulin resistance, obesity and diabetes
Dandona, P. (2004) · Trends in Immunology · doi:10.1016/j.it.2003.10.013 · Cited by 2,170 · cited 1×
“signaling [145, 146].”
Bard, F., Cannon, C., Barbour, R., Burke, R.-L., Games, D., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., et al. (2000) · Nature Medicine · doi:10.1038/78682 · Cited by 2,012 · cited 1×
“In fact, therapeutic intervention by administration of Ab antibodies appears to increase the clearance of Ab by activated microglia [115, 116].”
BackgroundDisruption of IRS-2 causes type 2 diabetes in mice
Withers, D. J., Gutierrez, J. S., Towery, H., Burks, D. J., Ren, J.-M., Previs, S., Zhang, Y., Bernal, D., Pons, S., Shulman, G. I., et al. (1998) · Nature · doi:10.1038/36116 · Cited by 1,775 · cited 1×
“Similar effects on brain GSK3 phosphorylation were observed in the IRS-2deficient mouse model of diabetes which had increased brain phospho-Ser9-GSK3b [135] and these mice are hyperglycemic [136].”
BackgroundEpithelial–mesenchymal transitions in development and pathologies
Thiery, J. P. (2003) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2003.10.006 · Cited by 1,704 · cited 1×
“The increased motility and invasiveness of cancer cells in the first phase of metastasis resemble the epithelial-mesenchymal transition during embryonic development [174].”
Zhou, B. P., Deng, J., Xia, W., Xu, J., Li, Y. M., Gunduz, M., & Hung, M.-C. (2004) · Nature Cell Biology · doi:10.1038/ncb1173 · Cited by 1,581 · cited 3×
“The transcription factor Snail has a fundamental role in the epithelial-mesenchymal transition by suppressing expression of the adhesion protein E-cadherin, and the level of Snail correlates with breast cancer metastases [170].”
BackgroundMicroglia and inflammation-mediated neurodegeneration: Multiple triggers with a common mechanism
Block, M. L., & Hong, J.-S. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.06.004 · Cited by 1,557
The glamour and gloom of glycogen synthase kinase-3
Jope, R. S., & Johnson, G. V. W. (2004) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2003.12.004 · Cited by 1,517 · cited 3×
“However, since complete inhibition of GSK3 would have widespread consequences on many cellular functions [3], even with both mechanisms of inhibition acting together a therapeutic level of lithium does not completely inhibit GSK3 but only reduces its maximal activity.”
BackgroundSelf-citationThe multifaceted roles of glycogen synthase kinase 3β in cellular signaling
Grimes, C. A., & Jope, R. S. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(01)00011-9 · Cited by 1,423
Self-citationInflammation and Activated Innate Immunity in the Pathogenesis of Type 2 Diabetes
Pickup, J. C. (2004) · Diabetes Care · doi:10.2337/diacare.27.3.813 · Cited by 1,414 · cited 1×
“TNF and IL-6 represent only two examples of numerous inflammatory molecules for which elevations have been linked to the development of type 2 diabetes, and several anti-inflammatory drugs have been reported to decrease the risk of developing type 2 diabetes [150].”
BackgroundRequirement for glycogen synthase kinase-3β in cell survival and NF-κB activation
Hoeflich, K. P., Luo, J., Rubie, E. A., Tsao, M.-S., Jin, O., & Woodgett, J. R. (2000) · Nature · doi:10.1038/35017574 · Cited by 1,393 · cited 11×
“This role of GSK3 in inflammation was first established by our report that GSK3 activity is necessary for full stimulation of the production of several pro-inflammatory cytokines, such as interleukin-6 (IL6), IL-1b, and tumor necrosis factor (TNF), following stimulation of several types of Toll-like receptors in monoc…”
BackgroundInfluentialMolecular cloning and expression of glycogen synthase kinase‐3/factor A.
Woodgett, J. R. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07419.x · Cited by 1,362 · cited 8×
“The example shows the substrate, glycogen synthase (GS), primed by casein kinase II (CKII) followed by sequential phosphorylation by GSK3 at multiple sites spaced four residues apart toward the N-terminal end of GS. (2) Phosphorylation of regulatory serine—a major mechanism for inhibiting the activity of GSK3 is by se…”
BackgroundInfluentialDissecting the metastatic cascade
Pantel, K., & Brakenhoff, R. H. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1370 · Cited by 1,281 · cited 1×
“Cells acquire an invasive capacity through changes in adhesiveness by proteolysis of the extracellular matrix and increased motility [173].”
BackgroundCytokines and major depression
Schiepers, O. J. G., Wichers, M. C., & Maes, M. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.11.003 · Cited by 1,235 · cited 1×
“tion may contribute to therapy based on both the (a) depressive effects that cytokines can produce, as well as (b) on much evidence that classical anti-depressants have anti-inflammatory effects [59, 63].”
BackgroundGSK-3α regulates production of Alzheimer's disease amyloid-β peptides
Phiel, C. J., Wilson, C. A., Lee, V. M.-Y., & Klein, P. S. (2003) · Nature · doi:10.1038/nature01640 · Cited by 1,196 · cited 2×
“Abnormal accumulation of Aβ is a critical early stage in AD neuropathology, and several studies have shown that Aβ production is promoted by GSK3 and reduced by GSK3 inhibitors [67–70].”
BackgroundLiu, B., & Hong, J.-S. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.035048 · Cited by 1,095 · cited 1×
“trocytes and microglia are not thought to be entirely detrimental in AD [113, 114].”
BackgroundMartin, M., Rehani, K., Jope, R. S., & Michalek, S. M. (2005) · Nature Immunology · doi:10.1038/ni1221 · Cited by 1,080
Self-citationLawlor, M. A., & Alessi, D. R. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.16.2903 · Cited by 1,071 · cited 1×
“and GSK3, which increases and decreases, respectively, their activities [123].”
BackgroundSchmidt, M. I., Duncan, B. B., Sharrett, A. R., Lindberg, G., Savage, P. J., Offenbacher, S., Azambuja, M. I., Tracy, R. P., & Heiss, G. (1999) · The Lancet · doi:10.1016/s0140-6736(99)01046-6 · Cited by 1,071 · cited 1×
“Overall, many studies have shown that in obesity and type 2 diabetes the plasma levels of inflammatory molecules are increased and these molecules can impede the actions of insulin, and similar studies suggest that elevated cytokine levels promote the development of type 2 diabetes [151].”
BackgroundRotter, V., Nagaev, I., & Smith, U. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301977200 · Cited by 1,062 · cited 1×
“IL-6 is well-documented to cause insulin-resistance in liver and fat [148, 149].”
BackgroundIntegrin-Mediated Activation of Cdc42 Controls Cell Polarity in Migrating Astrocytes through PKCζ
Etienne-Manneville, S., & Hall, A. (2001) · Cell · doi:10.1016/s0092-8674(01)00471-8 · Cited by 1,018 · cited 1×
“which is a key regulator of polarity and directional movement [27], inactivates GSK3 specifically in this complex by stimulating PKCf-induced inhibitory serine-phosphorylation of GSK3.”
BackgroundInflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis
Coussens, L. M., Raymond, W. W., Bergers, G., Laig-Webster, M., Behrendtsen, O., Werb, Z., Caughey, G. H., & Hanahan, D. (1999) · Genes & Development · doi:10.1101/gad.13.11.1382 · Cited by 946 · cited 1×
“On the other hand, attenuation of innate inflammation following GSK3 inhibition could explain the absence of an effect of lithium alone on tumor formation, since in the absence of infiltration of immune cells, components of tumor development, such as increased cell survival, tissue remodeling, angiogenesis, and suppre…”
BackgroundEmbi, N., Rylatt, D. B., & Cohen, P. (1980) · PubMed · Cited by 911
Adult mouse astrocytes degrade amyloid-β in vitro and in situ
Wyss-Coray, T., Loike, J. D., Brionne, T. C., Lu, E., Anankov, R., Yan, F., Silverstein, S. C., & Husemann, J. (2003) · Nature Medicine · doi:10.1038/nm838 · Cited by 909 · cited 1×
“Evidence indicates that astrocytes beneficially contribute to clearance of accumulated Ab [109, 110], but also contribute to inflammatory-induced neuronal damage such as by producing neurotoxic nitric oxide [111] and cytokines.”
BackgroundLucas, J. J. (2001) · The EMBO Journal · doi:10.1093/emboj/20.1.27 · Cited by 900 · cited 1×
“Furthermore, tau phosphorylation is increased in transgenic mice overexpressing GSK3b [99, 100].”
BackgroundGSK-3β Regulates Phosphorylation of CRMP-2 and Neuronal Polarity
Yoshimura, T., Kawano, Y., Arimura, N., Kawabata, S., Kikuchi, A., & Kaibuchi, K. (2005) · Cell · doi:10.1016/j.cell.2004.11.012 · Cited by 875
Cdc42 regulates GSK-3β and adenomatous polyposis coli to control cell polarity
Etienne-Manneville, S., & Hall, A. (2003) · Nature · doi:10.1038/nature01423 · Cited by 835 · cited 1×
“This inhibition of GSK3 prevents it from phosphorylating adenomatous polyposis coli (APC) protein which allows APC to associate with the plus-ends of microtubules to establish cell polarity and control the direction of cell protrusion [28].”
BackgroundEMBI, N., RYLATT, D. B., & COHEN, P. (1980) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1980.tb06059.x · Cited by 779
Cognition and synaptic plasticity in diabetes mellitus
Gispen, W. H., & Biessels, G.-J. (2000) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01656-8 · Cited by 772 · cited 1×
“In contrast to studies of the effects of diabetic conditions on peripheral tissues, little is understood about diabetes-associated changes in the brain even though cognition is often impaired in diabetic subjects [130].”
ResultHanger, D. P., Hughes, K., Woodgett, J. R., Brion, J.-P., & Anderton, B. H. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90774-2 · Cited by 737 · cited 1×
“Tau was identified as a substrate of GSK3b in vitro [90, 91] and in intact cells [92, 93] and GSK3 is now widely”
BackgroundInsulin signaling in health and disease
White, M. F. (2003) · Science · doi:10.1126/science.1092952 · Cited by 733 · cited 1×
“type 2 insulin-independent diabetes, which are increasingly prevalent conditions [119–121].”
BackgroundCombs, C. K., Karlo, J. C., Kao, S.-C., & Landreth, G. E. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-04-01179.2001 · Cited by 721
Noble, W., Planel, E., Zehr, C., Olm, V., Meyerson, J., Suleman, F., Gaynor, K., Wang, L., LaFrancois, J., Feinstein, B., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500466102 · Cited by 709 · cited 1×
“GSK3 can also regulate the splicing of tau [96], hyperphosphorylated tau itself can be neurotoxic [97], and inhibition of GSK3 protects cells from aggregated tau-induced neurotoxicity [98].”
BackgroundGriffin, W. S. T., Sheng, J. G., Royston, M. C., Gentleman, S. M., McKenzie, J. E., Graham, D. I., Roberts, G. W., & Mrak, R. E. (1998) · Brain Pathology · doi:10.1111/j.1750-3639.1998.tb00136.x · Cited by 708 · cited 1×
“Activated microglia also release inflammatory cytokines and nitric oxide, as well as reactive oxygen species, and activate the complement system [112].”
BackgroundMicroglia in health and disease
Kim, S. U., & de Vellis, J. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20562 · Cited by 663
The oncogenic activation of β-catenin
Polakis, P. (1999) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(99)80003-3 · Cited by 653 · cited 3×
“GSK3 phosphorylates many oncogenic factors such as the transcription factors c-Myc, β-catenin, Snail, and BCL3 to target them for degradation through the proteasome pathway [153,169, 170].”
BackgroundResultInfluentialInflammation as a Tumor Promoter in Cancer Induction
Philip, M., Rowley, D. A., & Schreiber, H. (2004) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2004.06.006 · Cited by 640 · cited 1×
“On the other hand, acute inflammation may contribute to the regression of cancer [181].”
BackgroundRole for neuronal insulin resistance in neurodegenerative diseases
Schubert, M., Gautam, D., Surjo, D., Ueki, K., Baudler, S., Schubert, D., Kondo, T., Alber, J., Galldiks, N., Küstermann, E., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308724101 · Cited by 637
Ho, L., Qin, W., Pompl, P. N., Xiang, Z., Wang, J., Zhao, Z., Peng, Y., Cambareri, G., Rocher, A., Mobbs, C. V., et al. (2004) · The FASEB Journal · doi:10.1096/fj.03-0978fje · Cited by 630 · cited 1×
“Thus, injection of insulin increased GSK3 phosphorylation in mouse brain [131] and brain GSK3 phosphorylation was reduced by blockade of insulin signaling by knockout of the insulin receptor [132] and in mice with diet-induced insulinresistance [133].”
BackgroundWNTS in the vertebrate nervous system: from patterning to neuronal connectivity
Ciani, L., & Salinas, P. C. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1665 · Cited by 543 · cited 1×
“The Wnt signaling protein complex composed of the tumor suppressor APC, the scaffold protein Axin, b-catenin, and GSK3 promotes the phosphorylation of b-catenin by GSK3 to target it for degradation by the proteasome [152].”
BackgroundChalecka-Franaszek, E., & Chuang, D.-M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8745 · Cited by 542 · cited 1×
“This serine-phosphorylation of GSK3 following its initial direct inhibition by lithium appears to be mediated by a feedback loop involving regulation of protein phosphatase-1 [52] or by increased Akt activity following lithium treatment [53].”
BackgroundBeurel, E., & Jope, R. S. (2006) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2006.07.006 · Cited by 541 · cited 1×
“An intrinsic feature of cancer cells is their resistance to apoptosis, so in addition to proliferation and migration, GSK3 may also be important in cancerous tissues because of the widespread regulatory role of GSK3 in apoptosis [175].”
BackgroundSelf-citationRing, D. B., Johnson, K. W., Henriksen, E. J., Nuss, J. M., Goff, D., Kinnick, T. R., Ma, S. T., Reeder, J. W., Samuels, I., Slabiak, T., et al. (2003) · Diabetes · doi:10.2337/diabetes.52.3.588 · Cited by 532 · cited 1×
“ered plasma glucose levels in a dose-dependent manner by as much as 50% [140].”
BackgroundThe Wnt signaling pathway and its role in tumor development
Lustig, B., & Behrens, J. (2003) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-003-0431-0 · Cited by 524 · cited 1×
“Considering the possibility that GSK3 inhibition may contribute to tumorigenesis, it is particularly interesting that no inactivating mutations in GSK3 have been found yet in human cancers [156].”
BackgroundOncogenic PI3K and its role in cancer
Samuels, Y., & Ericson, K. (2006) · Current Opinion in Oncology · doi:10.1097/01.cco.0000198021.99347.b9 · Cited by 521 · cited 2×
“This is in marked contrast to the relatively frequent mutations that have been found in human cancers in the genes encoding b-catenin or APC in the Wnt pathway or in components of the PI3K/Akt pathway [153, 155].”
BackgroundResultDestabilization of β-catenin by mutations in presenilin-1 potentiates neuronal apoptosis
Zhang, Z., Hartmann, H., Minh Do, V., Abramowski, D., Sturchler-Pierrat, C., Staufenbiel, M., Sommer, B., van de Wetering, M., Clevers, H., Saftig, P., et al. (1998) · Nature · doi:10.1038/27208 · Cited by 517 · cited 1×
“Furthermore, expression of an AD-related mutated presenilin1 activates GSK3 [72, 74, 75].”
BackgroundGlycogen synthase kinase‐3 and the Alzheimer‐like state of microtubule‐associated protein tau
Mandelkow, E.-M., Drewes, G., Biernat, J., Gustke, N., Van Lint, J., Vandenheede, J. R., & Mandelkow, E. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)81496-9 · Cited by 515 · cited 1×
“Tau was identified as a substrate of GSK3β in vitro [90,91] and in intact cells [92,93] and GSK3 is now widely acknowledged to be a bona fide tau kinase.”
BackgroundEtminan, M., Gill, S., & Samii, A. (2003) · BMJ · doi:10.1136/bmj.327.7407.128 · Cited by 511 · cited 1×
“It has been suggested that the variable results obtained in clinical trials are in part because long-term administration of NSAIDs is necessary to achieve beneficial effects, such as delayed progression and reduced symptomology, including a slower rate of cognitive decline [103, 118].”
BackgroundCartier, L., Hartley, O., Dubois-Dauphin, M., & Krause, K.-H. (2005) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.07.021 · Cited by 509 · cited 1×
“in many excellent reviews [11–16].”
Lithium and GSK-3: one inhibitor, two inhibitory actions, multiple outcomes
Jope, R. S. (2003) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(03)00206-2 · Cited by 500
Self-citationNSAIDs and Alzheimer disease: Epidemiological, animal model and clinical studies
McGeer, P. L., & McGeer, E. G. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.03.013 · Cited by 498 · cited 1×
“Although epidemiological evidence and studies in animal models provide a strong case for NSAID use in AD, clinical trials have provided mixed, and controversial, results [117].”
ResultLithium Inhibits Glycogen Synthase Kinase-3 by Competition for Magnesium
Ryves, W. J., & Harwood, A. J. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.4169 · Cited by 493 · cited 1×
“Lithium binds to GSK3 to directly inhibit its activity, acting as a competitive inhibitor with respect to magnesium [48].”
BackgroundInsulin Receptor Substrate-2 Deficiency Impairs Brain Growth and Promotes Tau Phosphorylation
Schubert, M., Brazil, D. P., Burks, D. J., Kushner, J. A., Ye, J., Flint, C. L., Farhang-Fallah, J., Dikkes, P., Warot, X. M., Rio, C., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-18-07084.2003 · Cited by 488 · cited 1×
“Similar effects on brain GSK3 phosphorylation were observed in the IRS-2deficient mouse model of diabetes which had increased brain phospho-Ser9-GSK3b [135] and these mice are hyperglycemic [136].”
BackgroundChronic Exposure to Interleukin-6 Causes Hepatic Insulin Resistance in Mice
Klover, P. J., Zimmers, T. A., Koniaris, L. G., & Mooney, R. A. (2003) · Diabetes · doi:10.2337/diabetes.52.11.2784 · Cited by 488 · cited 1×
“IL-6 is well-documented to cause insulin-resistance in liver and fat [148, 149].”
BackgroundLithium Reduces Tau Phosphorylation by Inhibition of Glycogen Synthase Kinase-3
Hong, M., Chen, D. C. R., Klein, P. S., & Lee, V. M.-Y. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.40.25326 · Cited by 469 · cited 1×
“Tau was identified as a substrate of GSK3b in vitro [90, 91] and in intact cells [92, 93] and GSK3 is now widely”
BackgroundLovestone, S., Reynolds, C. H., Latimer, D., Davis, D. R., Anderton, B. H., Gallo, J.-M., Hanger, D., Mulot, S., Marquardt, B., Stabel, S., et al. (1994) · Current Biology · doi:10.1016/s0960-9822(00)00246-3 · Cited by 469 · cited 1×
“Tau was identified as a substrate of GSK3β in vitro [90,91] and in intact cells [92,93] and GSK3 is now widely acknowledged to be a bona fide tau kinase.”
BackgroundControl of motile and invasive cell phenotypes by focal adhesion kinase
Schlaepfer, D. D., Mitra, S. K., & Ilic, D. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2004.04.008 · Cited by 440 · cited 1×
“Thus, FAK phosphorylates adhesion-associated proteins, such as paxillin, to disassemble adhesions and promote migration [35].”
BackgroundInhibitory Phosphorylation of Glycogen Synthase Kinase-3 (GSK-3) in Response to Lithium
Zhang, F., Phiel, C. J., Spece, L., Gurvich, N., & Klein, P. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212635200 · Cited by 435 · cited 1×
“This serine-phosphorylation of GSK3 following its initial direct inhibition by lithium appears to be mediated by a feedback loop involving regulation of protein phosphatase-1 [52] or by increased Akt activity following lithium treatment [53].”
BackgroundRegulation of Akt and glycogen synthase kinase-3β phosphorylation by sodium valproate and lithium
De Sarno, P., Li, X., & Jope, R. S. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00215-0 · Cited by 434 · cited 1×
“both in mouse brain [49] and in human blood cells [50], which has led to the hypothesis that lithium also”
BackgroundSelf-citationMicroglial phenotype: is the commitment reversible?
Schwartz, M., Butovsky, O., Brück, W., & Hanisch, U.-K. (2006) · Trends in Neurosciences · doi:10.1016/j.tins.2005.12.005 · Cited by 434
Contribution of inflammatory processes to Alzheimer's disease: molecular mechanisms
Sastre, M., Klockgether, T., & Heneka, M. T. (2006) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2005.11.014 · Cited by 426 · cited 1×
“It has been suggested that the variable results obtained in clinical trials are in part because long-term administration of NSAIDs is necessary to achieve beneficial effects, such as delayed progression and reduced symptomology, including a slower rate of cognitive decline [103, 118].”
BackgroundAstrocytes accumulate Aβ42 and give rise to astrocytic amyloid plaques in Alzheimer disease brains
Nagele, R. G., D’Andrea, M. R., Lee, H., Venkataraman, V., & Wang, H.-Y. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02361-8 · Cited by 416
O'Brien, W. T., Harper, A. D., Jové, F., Woodgett, J. R., Maretto, S., Piccolo, S., & Klein, P. S. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.4753-03.2004 · Cited by 415 · cited 1×
“Furthermore, large reductions in immobilization time in the forced swim test were induced not only by inhibition of GSK3 by lithium administration, but also by the lowered GSK3b levels expressed in heterozygote GSK3b mice [56].”
BackgroundUchida, Y., Ohshima, T., Sasaki, Y., Suzuki, H., Yanai, S., Yamashita, N., Nakamura, F., Takei, K., Ihara, Y., Mikoshiba, K., et al. (2005) · Genes to Cells · doi:10.1111/j.1365-2443.2005.00827.x · Cited by 410 · cited 1×
“Conversely, activation of GSK3 causes growth cone collapse in response to semaphorin stimulation in neurites [6], an effect likely related to phosphorylation by GSK3 of the microtubule-associated proteins CRMP2 [30, 31] and MAP1B [32], indicating that in contrast to local inhibition, local activation of GSK3 blocks th…”
BackgroundPresenilin 1 associates with glycogen synthase kinase-3β and its substrate tau
Takashima, A., Murayama, M., Murayama, O., Kohno, T., Honda, T., Yasutake, K., Nihonmatsu, N., Mercken, M., Yamaguchi, H., Sugihara, S., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9637 · Cited by 409 · cited 2×
“Furthermore, expression of an AD-related mutated presenilin1 activates GSK3 [72, 74, 75].”
BackgroundGlycogen synthase kinase 3: an emerging therapeutic target
Eldar-Finkelman, H. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(01)02266-3 · Cited by 407 · cited 1×
“to the regulation of glucose homeostasis, during the last few years increasing attention has been focused on diabetes-associated changes in GSK3 and the possibility that GSK3 may be a useful therapeutic target in diabetes to facilitate control of glucose levels [124].”
BackgroundIFN-γ Suppresses IL-10 Production and Synergizes with TLR2 by Regulating GSK3 and CREB/AP-1 Proteins
Hu, X., Paik, P. K., Chen, J., Yarilina, A., Kockeritz, L., Lu, T. T., Woodgett, J. R., & Ivashkiv, L. B. (2006) · Immunity · doi:10.1016/j.immuni.2006.02.014 · Cited by 406 · cited 1×
“Arthritis and peritonitis in mice were also reduced by in vivo administration of the GSK3 inhibitor lithium [25].”
BackgroundWelsh, G. I., & Proud, C. G. (1993) · Biochemical Journal · doi:10.1042/bj2940625 · Cited by 404 · cited 1×
“Additionally, since GSK3 also phosphorylates the translation factor eIF2B to inhibit protein synthesis [172], inhibition of GSK3 is favorable for cancerous proliferation.”
BackgroundTau protein kinase I is essential for amyloid beta-protein-induced neurotoxicity.
Takashima, A., Noguchi, K., Sato, K., Hoshino, T., & Imahori, K. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.16.7789 · Cited by 381 · cited 1×
“This appears not to be a ‘‘bystander’’ effect of GSK3 because treatment with Ab activates GSK3 in a number of conditions, indicating a direct link between Abinduced GSK3 activation and neurotoxicity [79, 86, 87].”
BackgroundVicente-Manzanares, M., Webb, D. J., & Horwitz, A. R. (2005) · Journal of Cell Science · doi:10.1242/jcs.02662 · Cited by 380 · cited 1×
“Cell migration has been conceptualized as a cyclic process of cell movement initiated by polarization of a cell [26].”
BackgroundLicinio, J., & Wong, M.-L. (1999) · Molecular Psychiatry · doi:10.1038/sj.mp.4000586 · Cited by 380 · cited 1×
“characteristic of mood disorders [60–62].”
Hanger, D. P., Betts, J. C., Loviny, T. L. F., Blackstock, W. P., & Anderton, B. H. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71062465.x · Cited by 377 · cited 1×
“hyperphosphorylated in AD brain [89, 95].”
Toll‐like receptors in central nervous system glial inflammation and homeostasis
Kielian, T. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.20767 · Cited by 361 · cited 1×
“of the nervous system [17–19].”
Nikoulina, S. E., Ciaraldi, T. P., Mudaliar, S., Mohideen, P., Carter, L., & Henry, R. R. (2000) · Diabetes · doi:10.2337/diabetes.49.2.263 · Cited by 357 · cited 1×
“vated approximately twofold in skeletal muscle samples from human patients with type 2 diabetes [128].”
BackgroundDe Ferrari, G. V., Chacón, M. A., Barría, M. I., Garrido, J. L., Godoy, J. A., Olivares, G., Reyes, A. E., Alvarez, A., Bronfman, M., & Inestrosa, N. C. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001208 · Cited by 332
Hayley, S., Poulter, M. O., Merali, Z., & Anisman, H. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.03.051 · Cited by 324
Cytokines: abnormalities in major depression and implications for pharmacological treatment
O'Brien, S. M., Scott, L. V., & Dinan, T. G. (2004) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.609 · Cited by 320
Essential role of BCL9-2 in the switch between β-catenin's adhesive and transcriptional functions
Brembeck, F. H., Schwarz-Romond, T., Bakkers, J., Wilhelm, S., Hammerschmidt, M., & Birchmeier, W. (2004) · Genes & Development · doi:10.1101/gad.317604 · Cited by 319
Spittaels, K., Van den Haute, C., Van Dorpe, J., Geerts, H., Mercken, M., Bruynseels, K., Lasrado, R., Vandezande, K., Laenen, I., Boon, T., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006219200 · Cited by 316 · cited 1×
“Furthermore, tau phosphorylation is increased in transgenic mice overexpressing GSK3β [99,100].”
BackgroundDistinct molecular forms of β-catenin are targeted to adhesive or transcriptional complexes
Gottardi, C. J., & Gumbiner, B. M. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200402153 · Cited by 315
Inflammatory responses to amyloidosis in a transgenic mouse model of Alzheimer’s disease
Matsuoka, Y., Picciano, M., Malester, B., LaFrancois, J., Zehr, C., Daeschner, J. M., Olschowka, J. A., Fonseca, M. I., O’Banion, M. K., Tenner, A. J., et al. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64085-0 · Cited by 303 · cited 1×
“Even transgenic mouse models of AD display inflammation and increased cytokine production [104, 105].”
BackgroundCytokines, stress and depressive illness: Brain-immune interactions.
Anisman, H., & Merali, Z. (2003) · Annals of Medicine · doi:10.1080/07853890310004075 · Cited by 302
In Vivo Regulation of Glycogen Synthase Kinase-3β (GSK3β) by Serotonergic Activity in Mouse Brain
Li, X., Zhu, W., Roh, M.-S., Friedman, A. B., Rosborough, K., & Jope, R. S. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300439 · Cited by 300 · cited 1×
“bition of GSK3 in mouse brain in vivo lends further support to the possibility that impaired control of GSK3 is a component of mood disorders [54].”
BackgroundSelf-citationEvidence for glial-mediated inflammation in aged APPSW transgenic mice
Benzing, W. C., Wujek, J. R., Ward, E. K., Shaffer, D., Ashe, K. H., Younkin, S. G., & Brunden, K. R. (1999) · Neurobiology of Aging · doi:10.1016/s0197-4580(99)00065-2 · Cited by 299 · cited 1×
“Even transgenic mouse models of AD display inflammation and increased cytokine production [104, 105].”
BackgroundSu, Y., Ryder, J., Li, B., Wu, X., Fox, N., Solenberg, P., Brune, K., Paul, S., Zhou, Y., Liu, F., et al. (2004) · Biochemistry · doi:10.1021/bi035627j · Cited by 296 · cited 1×
“These many interactions of GSK3 with Ab suggest that GSK3 inhibitors may be therapeutic, and this has been demonstrated in transgenic mouse models of AD in which administration of GSK3 inhibitors reduced the Ab burden [68, 70, 88].”
BackgroundHistone Hyperacetylation Is Associated with Amelioration of Experimental Colitis in Mice
Glauben, R., Batra, A., Fedke, I., Zeitz, M., Lehr, H. A., Leoni, F., Mascagni, P., Fantuzzi, G., Dinarello, C. A., & Siegmund, B. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.8.5015 · Cited by 293 · cited 1×
“Although, like lithium, the therapeutic mechanism of action of valproate is not known, it is of considerable interest that recent reports indicate that valproate also shares with lithium the ability to reduce inflammation and ameliorate inflammationassociated conditions in experimental animals [65, 66].”
BackgroundCho, J., & Johnson, G. V. W. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02155.x · Cited by 282 · cited 1×
“the ability of tau to bind and stabilize microtubules [94].”
BackgroundKaidanovich-Beilin, O., Milman, A., Weizman, A., Pick, C. G., & Eldar-Finkelman, H. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.01.008 · Cited by 276 · cited 1×
“Using the forced swim test, which is used to assess depressive behavior and the effects of therapeutic agents, administration of a peptide inhibitor of GSK3 rapidly induced anti-depressant-like behavioral effects [55].”
MethodShakoori, A., Ougolkov, A., Yu, Z. W., Zhang, B., Modarressi, M. H., Billadeau, D. D., Mai, M., Takahashi, Y., & Minamoto, T. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.07.041 · Cited by 272 · cited 1×
“In contrast, in colo-rectal cancer cell lines and colorectal tumors, the levels of GSK3β expression and its active form are higher in tumor cells than in their normal counterparts, but these cancers are often associated with mutations in βcatenin or APC which abrogate the normal function of GSK3 in the Wnt signaling p…”
BackgroundLithium protects cultured neurons against β‐amyloid‐induced neurodegeneration
Alvarez, G., Muñoz-Montaño, J. R., Satrústegui, J., Avila, J., Bogónez, E., & Dı́az-Nido, J. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00685-7 · Cited by 270
Direct, activating interaction between glycogen synthase kinase-3β and p53 after DNA damage
Watcharasit, P., Bijur, G. N., Zmijewski, J. W., Song, L., Zmijewska, A., Chen, X., Johnson, G. V. W., & Jope, R. S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122062299 · Cited by 266 · cited 1×
“For example, in neuroblastoma SHSY5Y cells [176] or in hepatoma cell lines [177, 178], inhibition of GSK3 impedes the apoptotic signaling pathway and thereby induces resistance to chemotherapeutic agents, such as camptothecin, etoposide, and 588 Neurochem Res (2007) 32:577–595”
BackgroundSelf-citationGlycogen Synthase Kinase-3β (GSK3β) Binds to and Promotes the Actions of p53
Watcharasit, P., Bijur, G. N., Song, L., Zhu, J., Chen, X., & Jope, R. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305870200 · Cited by 262 · cited 1×
“actions of major tumor suppressor proteins such as p53 [177, 179].”
BackgroundSelf-citationPlanel, E., Miyasaka, T., Launey, T., Chui, D.-H., Tanemura, K., Sato, S., Murayama, O., Ishiguro, K., Tatebayashi, Y., & Takashima, A. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.5561-03.2004 · Cited by 261 · cited 1×
“Thus, injection of insulin increased GSK3 phosphorylation in mouse brain [131] and brain GSK3 phosphorylation was reduced by blockade of insulin signaling by knockout of the insulin receptor [132] and in mice with diet-induced insulinresistance [133].”
BackgroundTakashima, A., Noguchi, K., Michel, G., Mercken, M., Hoshi, M., Ishiguro, K., & Imahori, K. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(95)12257-5 · Cited by 260 · cited 1×
“This appears not to be a ‘‘bystander’’ effect of GSK3 because treatment with Ab activates GSK3 in a number of conditions, indicating a direct link between Abinduced GSK3 activation and neurotoxicity [79, 86, 87].”
BackgroundIncreased glycogen synthase kinase-3 activity in diabetes- and obesity-prone C57BL/6J mice.
Eldar-Finkelman, H., Schreyer, S. A., Shinohara, M. M., LeBoeuf, R. C., & Krebs, E. G. (1999) · Diabetes · doi:10.2337/diabetes.48.8.1662 · Cited by 252 · cited 1×
“matically among tissues [125].”
TNFα Signaling in Depression and Anxiety: Behavioral Consequences of Individual Receptor Targeting
Simen, B. B., Duman, C. H., Simen, A. A., & Duman, R. S. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.10.013 · Cited by 250
Eickholt, B. J., Walsh, F. S., & Doherty, P. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200201098 · Cited by 243 · cited 3×
“Localized inhibition of GSK3 also occurs in growth cones [6].”
BackgroundCline, G. W., Johnson, K., Regittnig, W., Perret, P., Tozzo, E., Xiao, L., Damico, C., & Shulman, G. I. (2002) · Diabetes · doi:10.2337/diabetes.51.10.2903 · Cited by 228 · cited 1×
“inhibitor CHIR98023 lowered glucose concentrations in Zucker diabetic fatty rats during a glucose tolerance test [127, 141].”
BackgroundTau-Mediated Cytotoxicity in a Pseudohyperphosphorylation Model of Alzheimer's Disease
Fath, T., Eidenmüller, J., & Brandt, R. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-22-09733.2002 · Cited by 227 · cited 1×
“GSK3 can also regulate the splicing of tau [96], hyperphosphorylated tau itself can be neurotoxic [97], and inhibition of GSK3 protects cells from aggregated tau-induced neurotoxicity [98].”
BackgroundPTEN and GSK3β: key regulators of progression to androgen-independent prostate cancer
Mulholland, D. J., Dedhar, S., Wu, H., & Nelson, C. C. (2006) · Oncogene · doi:10.1038/sj.onc.1209020 · Cited by 216 · cited 1×
“Furthermore, silencing of GSK3β expression is frequently associated with advanced prostate cancer [162].”
BackgroundGlycogen Synthase Kinase 3β Functions To Specify Gene-Specific, NF-κB-Dependent Transcription
Steinbrecher, K. A., Wilson, W., Cogswell, P. C., & Baldwin, A. S. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.19.8444-8455.2005 · Cited by 205
Glycogen synthase kinase-3β is highly activated in nuclei and mitochondria
Bijur, G. N., & Jope, R. S. (2003) · NeuroReport · doi:10.1097/00001756-200312190-00025 · Cited by 203 · cited 1×
“where it is highly active [5], and in other subcellular”
BackgroundSelf-citationMechanisms of Cell Signaling and Inflammation in Alzheimers Disease
Ho, G., Drego, R., Hakimian, E., & Masliah, E. (2005) · Current Drug Target -Inflammation & Allergy · doi:10.2174/1568010053586237 · Cited by 199 · cited 1×
“loid plaques in AD brain [106–108].”
Decisions, decisions: β-catenin chooses between adhesion and transcription
Harris, T. J. C., & Peifer, M. (2005) · Trends in Cell Biology · doi:10.1016/j.tcb.2005.03.002 · Cited by 190
Kim, H.-S., Kim, E.-M., Lee, J.-P., Park, C. H., Kim, S., Seo, J.-H., Chang, K.-A., Yu, E., Jeong, S.-J., Chong, Y. H., et al. (2003) · The FASEB Journal · doi:10.1096/fj.03-0106fje · Cited by 183
Can 1000 Reviews Be Wrong? Actin, α-Catenin, and Adherens Junctions
Gates, J., & Peifer, M. (2005) · Cell · doi:10.1016/j.cell.2005.11.009 · Cited by 180
The neuroprotective role of inflammation in nervous system Injuries
Correale, J. D., & Villa, A. (2004) · Journal of Neurology · doi:10.1007/s00415-004-0649-z · Cited by 179 · cited 1×
“in many excellent reviews [11–16].”
Qiu, W. Q., Ye, Z., Kholodenko, D., Seubert, P., & Selkoe, D. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.10.6641 · Cited by 177 · cited 1×
“trocytes and microglia are not thought to be entirely detrimental in AD [113, 114].”
BackgroundPeng, G.-S., Li, G., Tzeng, N.-S., Chen, P.-S., Chuang, D.-M., Hsu, Y.-D., Yang, S., & Hong, J.-S. (2005) · Molecular Brain Research · doi:10.1016/j.molbrainres.2004.10.021 · Cited by 170 · cited 1×
“Although, like lithium, the therapeutic mechanism of action of valproate is not known, it is of considerable interest that recent reports indicate that valproate also shares with lithium the ability to reduce inflammation and ameliorate inflammationassociated conditions in experimental animals [65, 66].”
BackgroundYue, T.-L., Bao, W., Gu, J.-L., Cui, J., Tao, L., Ma, X.-L., Ohlstein, E. H., & Jucker, B. M. (2005) · Diabetes · doi:10.2337/diabetes.54.2.554 · Cited by 170 · cited 1×
“vated receptor agonist that also inhibits GSK3, reduced circulating blood glucose levels in Zucker diabetic fatty rats and in patients with type 2 diabetes [138, 139].”
BackgroundRyan, K. A., & Pimplikar, S. W. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200505078 · Cited by 168 · cited 1×
“In addition to Aβ, other cleavage products of the amyloid precursor protein also bind and/or activate GSK3, indicating multiple points of contact between GSK3 and metabolism of the amyloid precursor protein [76–78].”
BackgroundHauwel, M., Furon, E., Canova, C., Griffiths, M., Neal, J. W., & Gasque, P. (2005) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.12.012 · Cited by 167 · cited 1×
“in many excellent reviews [11–16].”
Trivedi, N., Marsh, P., Goold, R. G., Wood-Kaczmar, A., & Gordon-Weeks, P. R. (2005) · Journal of Cell Science · doi:10.1242/jcs.01697 · Cited by 166 · cited 1×
“For example, GSK3 is locally inhibited in growth cones [6], whereas conversely, the activity of GSK3 to phosphorylate MAP1B is reported to be spatially restricted to growing axons [7].”
Role of glycogen synthase kinase-3 in cancer: Regulation by Wnts and other signaling pathways
Manoukian, A. S., & Woodgett, J. R. (2002) · Advances in cancer research · doi:10.1016/s0065-230x(02)84007-6 · Cited by 163 · cited 1×
“which, for example, is associated with colorectal cancer [154].”
BackgroundLithium inhibits amyloid secretion in COS7 cells transfected with amyloid precursor protein C100
Sun, X., Sato, S., Murayama, O., Murayama, M., Park, J.-M., Yamaguchi, H., & Takashima, A. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(01)02583-6 · Cited by 161 · cited 1×
“Abnormal accumulation of Aβ is a critical early stage in AD neuropathology, and several studies have shown that Aβ production is promoted by GSK3 and reduced by GSK3 inhibitors [67–70].”
BackgroundInsulin Mimetic Action of Synthetic Phosphorylated Peptide Inhibitors of Glycogen Synthase Kinase-3
Plotkin, B., Kaidanovich‐Beilin, O., Talior‐Volodarsky, I., & Eldar-Finkelman, H. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.047381 · Cited by 161 · cited 1×
“Administration of a peptide inhibitor of GSK3 increased glucose tolerance in diabetic mice [137].”
BackgroundGSK3-Mediated BCL-3 Phosphorylation Modulates Its Degradation and Its Oncogenicity
Viatour, P., Dejardin, E., Warnier, M., Lair, F., Claudio, E., Bureau, F., Marine, J., Merville, M., Maurer, U., Green, D. R., et al. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.09.004 · Cited by 158
Immunotherapy for Alzheimer's disease
Gelinas, D. S., DaSilva, K., Fenili, D., St. George-Hyslop, P., & McLaurin, J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404866101 · Cited by 157
Tau Protein in Normal and Alzheimer's Disease Brain: An Update
Johnson, G. V. W., & Hartigan, J. A. (1999) · Journal of Alzheimer’s Disease · doi:10.3233/jad-1999-14-512 · Cited by 156 · cited 1×
“microtubules and thus to neuronal structure [89].”
Molecular bases of the immune response to neural antigens
Lampson, L. A. (1987) · Trends in Neurosciences · doi:10.1016/0166-2236(87)90153-6 · Cited by 155 · cited 1×
“The blood brain barrier serves to separate the brain’s local inflammatory responses from systemic inflammation by limiting the penetration of peripheral inflammatory mediators and only allowing the penetration of leukocytes when appropriate signals are received [9, 10].”
BackgroundKinase-Inactive Glycogen Synthase Kinase 3β Promotes Wnt Signaling and Mammary Tumorigenesis
Farago, M., Dominguez, I., Landesman-Bollag, E., Xu, X., Rosner, A., Cardiff, R. D., & Seldin, D. C. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1021 · Cited by 148 · cited 1×
“Thus, transgenic mice overexpressing a kinase-inactive GSK3b under the control of the mouse mammary tumor virus-long terminal repeat develop more mammary tumors than control mice [165].”
BackgroundHeneka, M. T., Wiesinger, H., Dumitrescu-Ozimek, L., Riederer, P., Feinstein, D. L., & Klockgether, T. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.9.906 · Cited by 147 · cited 1×
“Evidence indicates that astrocytes beneficially contribute to clearance of accumulated Ab [109, 110], but also contribute to inflammatory-induced neuronal damage such as by producing neurotoxic nitric oxide [111] and cytokines.”
BackgroundGSK-3β inhibitors attenuate the organ injury/dysfunction caused by endotoxemia in the rat*
Dugo, L., Collin, M., Allen, D. A., Patel, N. S. A., Bauer, I., Mervaala, E. M. A., Louhelainen, M., Foster, S. J., Yaqoob, M. M., & Thiemermann, C. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000178350.21839.44 · Cited by 144 · cited 1×
“GSK3 inhibitors were reported to reduce the systemic inflammatory response, renal dysfunction, and hepatotoxicity associated with endotoxemia in rats [22].”
BackgroundDivergent roles of GSK3 and CDK5 in APP processing
Ryder, J. W., Yuan, S., Liu, F., Li, B., Zhou, Y., & Ni, B. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.11.014 · Cited by 143 · cited 1×
“These many interactions of GSK3 with Ab suggest that GSK3 inhibitors may be therapeutic, and this has been demonstrated in transgenic mouse models of AD in which administration of GSK3 inhibitors reduced the Ab burden [68, 70, 88].”
BackgroundSignal transduction during amyloid-β-peptide neurotoxicity: role in Alzheimer disease
Fuentealba, R. A., Farías, G. G., Scheu, J., Bronfman, M., Marzolo, M., & Inestrosa, N. C. (2004) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.07.018 · Cited by 140
Mutant Presenilin-1 Induces Apoptosis and Downregulates Akt/PKB
Weihl, C. C., Ghadge, G. D., Kennedy, S. G., Hay, N., Miller, R. J., & Roos, R. P. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-13-05360.1999 · Cited by 137 · cited 1×
“Furthermore, expression of an AD-related mutated presenilin1 activates GSK3 [72, 74, 75].”
BackgroundWei, H., Leeds, P. R., Qian, Y., Wei, W., Chen, R., & Chuang, D. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00127-8 · Cited by 136
Hernández, F., Pérez, M., Lucas, J. J., Mata, A. M., Bhat, R., & Avila, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311512200 · Cited by 135
Inflammation in the CNS: balance between immunological privilege and immune responses
Matyszak, M. K. (1998) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00014-8 · Cited by 133 · cited 1×
“in many excellent reviews [11–16].”
Glycogen Synthase Kinase 3 and h-prune Regulate Cell Migration by Modulating Focal Adhesions
Kobayashi, T., Hino, S.-I., Oue, N., Asahara, T., Zollo, M., Yasui, W., & Kikuchi, A. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.3.898-911.2006 · Cited by 127 · cited 1×
“promote cell migration [39].”
Oncogenic K-ras Stimulates Wnt Signaling in Colon Cancer Through Inhibition of GSK-3β
Li, J., Mizukami, Y., Zhang, X., Jo, W., & Chung, D. C. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.02.067 · Cited by 125
Tau protein I is essential for amyloid β-protein iduced neurotoxicity
Takashima, A. (1993) · Medical Entomology and Zoology · Cited by 125
Physiological and Pathological Changes in Glucose Regulate Brain Akt and Glycogen Synthase Kinase-3
Clodfelder-Miller, B., De Sarno, P., Zmijewska, A. A., Song, L., & Jope, R. S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m508824200 · Cited by 123 · cited 1×
“Thus, it was initially surprising to find that insulin depletion, which is associated with hyperglycemia, greatly increased the phosphorylation of GSK3 in mouse brain [134].”
BackgroundSelf-citationPearce, N. J., Arch, J. R. S., Clapham, J. C., Coghlan, M. P., Corcoran, S. L., Lister, C. A., Llano, A., Moore, G. B. T., Murphy, G. J., Smith, S. A., et al. (2004) · Metabolism · doi:10.1016/j.metabol.2004.05.008 · Cited by 122 · cited 1×
“Consistent with this, overexpression of GSK3b in skeletal muscle was sufficient to cause glucose intolerance [142].”
BackgroundCancer morbidity in psychiatric patients: influence of lithium carbonate treatment
Cohen, Y., Chetrit, A., Cohen, Y., Sirota, P., & Modan, B. (1998) · Medical Oncology · doi:10.1007/bf02787342 · Cited by 120 · cited 1×
“general population [167], although this result should be interpreted cautiously because it still needs to be”
BackgroundLi, X., Friedman, A. B., Zhu, W., Wang, L., Boswell, S., May, R., Davis, L. L., & Jope, R. S. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.02.027 · Cited by 120 · cited 1×
“both in mouse brain [49] and in human blood cells [50], which has led to the hypothesis that lithium also”
BackgroundSelf-citationOwen, R., & Gordon‐Weeks, P. R. (2003) · Molecular and Cellular Neuroscience · doi:10.1016/s1044-7431(03)00095-2 · Cited by 119 · cited 3×
“For example, GSK3 is locally inhibited in growth cones [6], whereas conversely, the activity of GSK3 to phosphorylate MAP1B is reported to be spatially restricted to growing axons [7].”
BackgroundCampbell, I. L. (2005) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.12.006 · Cited by 117 · cited 1×
“of the nervous system [17–19].”
Magrané, J., Rosen, K. M., Smith, R. C., Walsh, K., Gouras, G. K., & Querfurth, H. W. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1723-05.2005 · Cited by 113 · cited 1×
“This appears not to be a ‘‘bystander’’ effect of GSK3 because treatment with Ab activates GSK3 in a number of conditions, indicating a direct link between Abinduced GSK3 activation and neurotoxicity [79, 86, 87].”
BackgroundLi, X., Ketter, T. A., & Frye, M. A. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(00)00361-x · Cited by 108 · cited 1×
“Furthermore, sodium valproate has recently become very widely used as a mood stabilizer to treat bipolar disorder [64].”
BackgroundHenriksen, E. J., Kinnick, T. R., Teachey, M. K., O'Keefe, M. P., Ring, D., Johnson, K. W., & Harrison, S. D. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00346.2002 · Cited by 108 · cited 1×
“inhibitor CHIR98023 lowered glucose concentrations in Zucker diabetic fatty rats during a glucose tolerance test [127, 141].”
BackgroundGlycogen Synthase Kinase-3β Regulates Presenilin 1 C-terminal Fragment Levels
Kirschenbaum, F., Hsu, S.-C., Cordell, B., & McCarthy, J. V. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102849200 · Cited by 100
Bianchi, M., De Lucchini, S., Marin, O., Turner, D. L., Hanks, S. K., & Villa-Moruzzi, E. (2005) · Biochemical Journal · doi:10.1042/bj20050282 · Cited by 100 · cited 1×
“[36].”
Overexpression of Insulin Receptor Substrate-2 in Human and Murine Hepatocellular Carcinoma
Boissan, M., Beurel, E., Wendum, D., Rey, C., Lécluse, Y., Housset, C., Lacombe, M., & Desbois‐Mouthon, C. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62058-5 · Cited by 100 · cited 3×
“reported in human hepatocellular carcinoma [157, 159] and in human hepatoma cell lines [160].”
BackgroundSelf-citationProtein kinase CKII regulates the interaction of β-catenin withα-catenin and its protein stability
Bek, S., & Kemler, R. (2002) · Journal of Cell Science · doi:10.1242/jcs.00154 · Cited by 93
Reduction of experimental colitis in the rat by inhibitors of glycogen synthase kinase‐3 β
Whittle, B. J. R., Varga, C., Pósa, A., Molnár, A., Collin, M., & Thiemermann, C. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706509 · Cited by 93 · cited 1×
“In other inflammatory conditions, GSK3 inhibitors diminished inflammatory responses in experimentally induced colitis in rats [23] and in arthritis caused by administration of type II collagen in mice [24].”
BackgroundCai, X., Li, M., Vrana, J., & Schaller, M. D. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.7.2857-2868.2006 · Cited by 85
Gotoh, J., Obata, M., Yoshie, M., Kasai, S., & Ogawa, K. (2003) · Carcinogenesis · doi:10.1093/carcin/24.3.435 · Cited by 85 · cited 1×
“rectal cancer cell lines and colorectal tumors, the levels of GSK3b expression and its active form are higher in tumor cells than in their normal counterparts, but these cancers are often associated with mutations in b-catenin or APC which abrogate the normal function of GSK3 in the Wnt signaling pathway [163, 164].”
BackgroundExpression of junctional adhesion molecule-A prevents spontaneous and random motility
Bazzoni, G., Tonetti, P., Manzi, L., Cera, M. R., Balconi, G., & Dejana, E. (2005) · Journal of Cell Science · doi:10.1242/jcs.01661 · Cited by 84 · cited 1×
“PKCf-induced inhibition of GSK3 has also been shown to abolish random motility of endothelial cells [29].”
BackgroundImitola, J., Chitnis, T., & Khoury, S. J. (2006) · Archives of Neurology · doi:10.1001/archneur.63.1.25 · Cited by 83 · cited 1×
“of the nervous system [17–19].”
Beurel, E., Kornprobst, M., Eggelpoël, M.-J. B.-V., Ruiz‐Ruiz, C., Cadoret, A., Capeau, J., & Desbois‐Mouthon, C. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.08.001 · Cited by 82 · cited 3×
“For example, in neuroblastoma SHSY5Y cells [176] or in hepatoma cell lines [177, 178], inhibition of GSK3 impedes the apoptotic signaling pathway and thereby induces resistance to chemotherapeutic agents, such as camptothecin, etoposide, and 588 Neurochem Res (2007) 32:577–595”
BackgroundSelf-citationDysregulation of glycogen synthase kinase-3β signaling in hepatocellular carcinoma cells
Desbois‐Mouthon, C., Eggelpoël, M.-J. B.-V., Beurel, E., Boissan, M., Delélo, R., Cadoret, A., & Capeau, J. (2002) · Hepatology · doi:10.1053/jhep.2002.37192 · Cited by 82 · cited 1×
“Similarly, constitutive inhibition of GSK3β has been reported in human hepatocellular carcinoma [157,159] and in human hepatoma cell lines [160].”
BackgroundSelf-citationGSK-3β phosphorylation and alteration of β-catenin in hepatocellular carcinoma
Ban, K. C., Singh, H., Krishnan, R., & Seow, H. F. (2003) · Cancer Letters · doi:10.1016/s0304-3835(03)00421-x · Cited by 77 · cited 1×
“reported in human hepatocellular carcinoma [157, 159] and in human hepatoma cell lines [160].”
BackgroundPin1 promotes production of Alzheimer’s amyloid β from β-cleaved amyloid precursor protein
Akiyama, H., Shin, R., Uchida, C., Kitamoto, T., & Uchida, T. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.08.130 · Cited by 72
Cellular localization and signaling activity of β‐catenin in migrating neural crest cells
de Melker, A. A., Desban, N., & Duband, J. (2004) · Developmental Dynamics · doi:10.1002/dvdy.20091 · Cited by 71 · cited 1×
“Increasing β-catenin levels by using a selective GSK3 inhibitor or treatment with Wnt-1 inhibited neural crest cell spreading and migration [40].”
BackgroundGoto, H., Kawano, K., Kobayashi, I., Sakai, H., & Yanagisawa, S. (2002) · Oral Oncology · doi:10.1016/s1368-8375(01)00121-x · Cited by 70 · cited 1×
“carcinoma of the tongue [161].”
Ghribi, O., Herman, M. M., & Savory, J. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10511 · Cited by 67
Reynolds, J. L., Ignatowski, T. A., Sud, R., & Spengler, R. N. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.02.023 · Cited by 66 · cited 1×
“tion may contribute to therapy based on both the (a) depressive effects that cytokines can produce, as well as (b) on much evidence that classical anti-depressants have anti-inflammatory effects [59, 63].”
BackgroundLaviola, L., Belsanti, G., Davalli, A. M., Napoli, R., Perrini, S., Weir, G. C., GIORGINO, R., & Giorgino, F. (2001) · Diabetes · doi:10.2337/diabetes.50.12.2709 · Cited by 66 · cited 1×
“phosphorylation of GSK3 in the myocardium of diabetic rats [129].”
BackgroundLeis, H., Segrelles, C., Ruiz, S., Santos, M., & Paramio, J. M. (2002) · Molecular Carcinogenesis · doi:10.1002/mc.10087 · Cited by 65 · cited 1×
“ous injection of Akt-transformed keratinocytes, GSK3b activity is downregulated by Tyr216 dephosphorylation and increased Ser9 phosphorylation [158].”
BackgroundImmunotherapy for Alzheimer’s disease
(2005) · Alzheimer's Disease and Related Disorders · doi:10.1201/b13935-7 · Cited by 65
Gould, T. D., Gray, N. A., & Manji, H. K. (2003) · Pharmacological Research · doi:10.1016/s1043-6618(03)00096-3 · Cited by 64 · cited 1×
“Consistent with this, genetically predisposed APC mutant mice treated with lithium for 60 days do not develop a significantly increased number of tumors [168].”
BackgroundTakashima, A., Yamaguchi, H., Noguchi, K., Michel, G., Ishiguro, K., Sato, K., Hoshino, T., Hoshi, M. M., & Imahori, K. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11964-x · Cited by 60 · cited 1×
“Aβ is well-known to cause neuronal death when applied to cultured cells or to brain in vivo, and inhibition of GSK3 by a variety of methods significantly attenuates the neurotoxicity caused by Aβ [79–85].”
BackgroundSmith, S. A., Porter, L. E., Biswas, N., & Freed, M. I. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0705 · Cited by 54 · cited 1×
“vated receptor agonist that also inhibits GSK3, reduced circulating blood glucose levels in Zucker diabetic fatty rats and in patients with type 2 diabetes [138, 139].”
BackgroundSDF1α/CXCR4 signaling stimulates β-catenin transcriptional activity in rat neural progenitors
Luo, Y., Cai, J., Xue, H., Mattson, M. P., & Rao, M. S. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.01.024 · Cited by 53 · cited 1×
“Activation of the CXCR4 chemokine receptor was also reported to increase b-catenin levels and regulate cell migration [41].”
BackgroundFocal Adhesion Kinase (FAK) Regulates Insulin-stimulated Glycogen Synthesis in Hepatocytes
Huang, D., Cheung, A. T., Parsons, J. T., & Bryer-Ash, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m104252200 · Cited by 49 · cited 1×
“some situations [37].”
Farooqui, R., Zhu, S., & Fenteany, G. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2006.01.018 · Cited by 47 · cited 1×
“As opposed to local regulation, inhibition of total cellular GSK3 prevented migration of epithelial cells [33] and extension of lamellipodia in keratinocytes [34] and filopodia in neurons [32].”
BackgroundAplin, A. E., Jacobsen, J. S., Anderton, B. H., & Gallo, J.-M. (1997) · NeuroReport · doi:10.1097/00001756-199702100-00012 · Cited by 43 · cited 1×
“Nevertheless, the mechanism whereby GSK3 promotes Ab production remains to be clarified, perhaps being associated with the reported phosphorylation of the amyloid precursor protein by GSK3 [71] or the binding of GSK3 to presenilin-1 [72], because GSK3 phosphorylates and regulates the processing of presenilin-1 [73].”
BackgroundEffects of diabetes, vanadium, and insulin on glycogen synthase activation in Wistar rats
Semiz, S., Orvig, C., & McNeill, J. H. (2002) · Molecular and Cellular Biochemistry · doi:10.1023/a:1014437019586 · Cited by 43 · cited 1×
“activity [126, 127].”
C‐terminal fragment of amyloid precursor protein induces astrocytosis
Bach, J., Chae, H. S., Rah, J. C., Lee, M. W., Park, C. H., Choi, S. H., Choi, J. K., Lee, S. H., Kim, Y. S., Kim, K. Y., et al. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00370.x · Cited by 42 · cited 1×
“loid plaques in AD brain [106–108].”
Koivisto, L., Häkkinen, L., Matsumoto, K., McCulloch, C. A., Yamada, K. M., & Larjava, H. (2003) · Experimental Cell Research · doi:10.1016/j.yexcr.2003.09.026 · Cited by 35 · cited 1×
“As opposed to local regulation, inhibition of total cellular GSK3 prevented migration of epithelial cells [33] and extension of lamellipodia in keratinocytes [34] and filopodia in neurons [32].”
BackgroundManipulation of glycogen-synthase kinase-3 activity in KSHV-associated cancers
Fujimuro, M., & Hayward, S. D. (2004) · Journal of Molecular Medicine · doi:10.1007/s00109-003-0519-7 · Cited by 35 · cited 1×
“Thus, redistribution of GSK3 in the cell based on the loss of cytoplasmic GSK3 activity has been identified as another mechanism by which, for example, b-catenin can be dysregulated and contribute to human cancers [166].”
BackgroundGSK-3β reactivation with LY294002 sensitizes hepatoma cells to chemotherapy-induced apoptosis
Beurel, E., Kornprobst, M., Eggelpoël, M.-J. B.-V., Cadoret, A., Capeau, J., & Desbois‐Mouthon, C. (2005) · International Journal of Oncology · doi:10.3892/ijo.27.1.215 · Cited by 29 · cited 1×
“For example, in neuroblastoma SHSY5Y cells [176] or in hepatoma cell lines [177, 178], inhibition of GSK3 impedes the apoptotic signaling pathway and thereby induces resistance to chemotherapeutic agents, such as camptothecin, etoposide, and 588 Neurochem Res (2007) 32:577–595”
BackgroundSelf-citationFRAT1 peptide decreases Aβ production in swAPP751 cells
Li, B., Ryder, J. W., Yuan, S., Zhou, Y., Liu, F., & Ni, B. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)01042-1 · Cited by 15
Immunology of Transplantation in the Central Nervous Sylftem
Fuchs, H. E., & Bullard, D. E. (1988) · Stereotactic and Functional Neurosurgery · doi:10.1159/000099973 · Cited by 15 · cited 1×
“The blood brain barrier serves to separate the brain’s local inflammatory responses from systemic inflammation by limiting the penetration of peripheral inflammatory mediators and only allowing the penetration of leukocytes when appropriate signals are received [9, 10].”
BackgroundPeng, Gs, Li, Tzeng, Chen, C., Ps, Chuang, Hsu, Yang, & Hồng (2006) · 中国生物学文摘 · Cited by 10
Cited by
Glycogen synthase kinase-3 (GSK3): Regulation, actions, and diseases
Beurel, E., Grieco, S. F., & Jope, R. S. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.11.016 · Cited by 1,768
“Diseases involving inflammation in the periphery have also been shown to benefit from the anti-inflammatory effects of GSK3 inhibitors (Jope et al., 2007).”
BackgroundInfluentialSelf-citationThe GSK3 hypothesis of Alzheimer’s disease
Hooper, C., Killick, R., & Lovestone, S. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05194.x · Cited by 1,191
“Insulin transiently increases tau phosphorylation in human neuroblastoma cells, but this is soon followed by a reduction in tau phosphorylation, which correlates with the activation and subsequent inhibition of GSK3 (Lesort et al. 1999).”
BackgroundGSK-3β, a pivotal kinase in Alzheimer disease
Llorens-MarÃtin, M., Jurado, J., Hernández, F., & Ãvila, J. (2014) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2014.00046 · Cited by 451
“GSK-3β itself is an important positive regulator of the inflammatory process (Martin et al., 2005; Jope et al., 2007).”
BackgroundGlycogen synthase kinase 3β (GSK3β) in tumorigenesis and cancer chemotherapy
Luo, J. (2009) · Cancer Letters · doi:10.1016/j.canlet.2008.05.045 · Cited by 429
“Glycogen synthase kinase 3 (GSK3) has become one of the most attractive therapeutic targets for the treatment of diabetes, inflammation, and multiple neurological diseases, including Alzheimer’s, stroke and bipolar disorders [1,2].”
Therapeutic potential of mood stabilizers lithium and valproic acid:Beyond bipolar disorder
Chiu, C.-T., Wang, Z., Hunsberger, J. G., & Chuang, D.-M. (2013) · Pharmacological Reviews · doi:10.1124/pr.111.005512 · Cited by 404
Metadata
- Authors
- Jope, R. S., Yuskaitis, C. J., & Beurel, E.
- Affiliations
- University of Alabama at Birmingham (US)
- Corresponding author
- Jope, Richard S.
- Venue
- Neurochemical Research
- Published
- 2006-08-30
- Volume
- 32
- Issue
- 4-5
- Pages
- 577-595
- ISSN
- 0364-3190 (ISSN-L)
- 1573-6903
- PMC
- PMC1970866
- OpenAlex
- W1975454216
- Cited by
- 774
- References
- 192
- Citations by year
- 2026: 14 · 2025: 26 · 2024: 35 · 2023: 24 · 2022: 35 · 2021: 44 · 2020: 55 · 2019: 48 · 2018: 48 · 2017: 36 · 2016: 51 · 2015: 36 · 2014: 54 · 2013: 63 · 2012: 42
- FWCI
- 2.17
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neurochemical Research (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Institute of Mental Health (R01MH038752)
- National Institute of Neurological Disorders and Stroke (R01NS037768)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- glycogen synthase kinase-3, GSK3 inhibition, inflammation, mood disorders, Alzheimer's disease, diabetes mellitus, cancer, cell migration, inflammatory mediators, GSK-3 inhibitors
- MeSH terms
- Alzheimer Disease, Animals, Anti-Inflammatory Agents, Mental Disorders, Cell Movement, Diabetes Mellitus, Humans, Inflammation, Neoplasms, Gene Expression Regulation, Enzymologic, Glycogen Synthase Kinase 3
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.